Fecal microbiota transplant (FMT) is currently recommended for recurrent Clostridioidesdifficile infection. However, it is interesting to acknowledge the potential therapeutic role in other diseases associated with dysbiosis. This review will focus on the current and potential indications of FMT in gastrointestinal diseases, evaluating the available evidence and also exposing the necessary requirements to carry it out.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.gastrohep.2021.05.009 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!